Salesforce Plunges 40% in 2026 Despite AI Booking Surge – Proof of Monetization Required

What happened

Salesforce's stock has fallen to a 52-week low, down approximately 40% in 2026, as the market discounts AI monetization risks despite a tripling of AI annual recurring revenue. The company reported Q1 FY27 results with cRPO growth of 14% and Agentforce ARR reaching ~$1.2B, but investors remain skeptical that AI consumption pricing can convert into durable contracted revenue. The DeepValue report rates CRM a POTENTIAL BUY with a base-case valuation of $220, assuming cRPO sustains low-to-mid teens growth and GAAP operating margins near 21%. However, the stock is trading at $197.9, and the margin of safety is limited, as the company increased debt to $39.5B to fund a $25B ASR, raising balance-sheet risk. The next two quarters are critical to validate whether AI attach generates multi-year commitments or remains variable spend.

Implication

The stock's decline to $197.9 presents an opportunity only if cRPO growth holds at 12-14% for the next two quarters, proving AI monetization is contracting into backlog. Without this confirmation, the bear case of $160 becomes more likely as procurement throttles variable AI spend. The elevated debt from the ASR reduces the safety net, making sustained backlog growth essential. If cRPO falls below 10%, the thesis breaks and further downside is probable. Conversely, sustained low-teens growth could trigger a rerating toward $220, as the market re-evaluates AI as a tailwind rather than a structural risk.

Thesis delta

The core thesis remains that Salesforce's AI expansion will convert into durable contracted revenue, but the stock's severe sell-off reflects growing market skepticism that consumption pricing undermines SaaS visibility. The delta is that debt-financed buybacks reduce the margin of safety, making the next two quarterly prints decisive. If cRPO continues to grow at low-to-mid teens, the current price offers an attractive entry; if it decelerates, the downside risk to $160 is elevated.